NASDAQ:INSM

Insmed Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$26.52

+1.50 (+6.00%)

At Close: Dec 01, 2023

Currently predicting for Mon, 4 Dec 2023

Trading levels for INSM

Support & Resistance - Acc. volume What is stop-loss?

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	27.88	5.11 %
		R2	27.10	2.20 %
		R1	26.63	0.397 %
Current price:			26.52
	Support	S1	25.08	-5.43 %
		S2	24.60	-7.24 %
		S3	23.83	-10.15 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	26.67	0.566 %
		R2	26.61	0.339 %
		R1	26.59	0.264 %
Current price			26.52
	Support	S1	26.43	-0.339%
		S2	26.37	-0.566%
		S3	24.44	-7.84%

INSM Predictions History

3 years ago
Lennon Pierce predicted that INSM for 2020-01-09 is going $26.70 (3.45%)

Rank:

4 years ago
GoldenNugget predicted that INSM for 2019-05-07 is going $31.10 (-3.40%)

4 years ago
NameNotImportant predicted that INSM for 2019-05-06 is going $30.44 (-3.15%)

4 years ago
NameNotImportant predicted that INSM for 2019-05-02 is going $28.74 (-3.33%)

About Insmed

Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Golden Star

Ticker	Date	Change	Price
PAGP	Nov 29	2.64%	$15.92
AMRC	Nov 29	11.93%	$28.34
ESS	Nov 29	3.97%	$212.23
CP	Nov 29	4.92%	$71.32
AN	Nov 29	4.47%	$134.13
AZN	Nov 29	1.04%	$64.12
CGNX	Nov 27	4.52%	$36.74
WEC	Nov 24	4.05%	$81.66
PEAK	Nov 24	9.31%	$16.65
NAVI	Nov 24	5.11%	$16.84

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In